About Barry R. Davis, MD, PhD
Barry R. Davis is a physician-scientist, biostatistician, and clinical trialist whose career has centered on prevention — not only as a medical strategy, but as a societal responsibility.
He is Professor Emeritus of Biostatistics and Data Science at UTHealth Houston School of Public Health, where he previously served as Chair of the Department and Director of the Coordinating Center for Clinical Trials. He also held the Guy S. Parcel Chair in Public Health. Based in Houston and the Texas Medical Center, his work has shaped national and international approaches to cardiovascular prevention.
Dr. Davis served as Principal Investigator of ALLHAT, one of the largest hypertension trials ever conducted, and led SHEP, a landmark study demonstrating the benefits of treating systolic hypertension in older adults. He also held leadership roles in the Hypertension Detection and Follow-up Program (HDFP). He contributed to the early development of the SPRINT trial and later served on its Data and Safety Monitoring Committee.
In addition to directing large-scale trials, he has served on more than 150 Data and Safety Monitoring Committees and held leadership roles in national and international professional societies.
Honors and Recognition
Delta Omega National Honorary Membership (2026)
On November 2, 2026, Barry R. Davis, MD, PhD, was formally inducted as a National Honorary Member of Delta Omega, the national honorary society for public health, at its annual ceremony during the American Public Health Association meeting in San Antonio.
Delta Omega periodically confers honorary membership upon persons possessing exceptional qualifications, who have attained meritorious national or international distinction in the field of public health. Dr. Davis was recognized for his leadership in landmark cardiovascular clinical trials, his expertise in biostatistics, and his dedication to the science of preventive medicine as well as his contribution to public advocacy with his book, The Preventioneers: Diseases, Disasters, and the Discoveries That Changed Our World.
Previous National Honorary Members include Anthony Fauci, Vivek Murthy, Mandy Cohen, and Richard Besser. The honor carries a special historical connection. Sara Josephine Baker, one of the pioneering public health figures featured in The Preventioneers, received the same distinction in 1924, more than a century earlier.

From Research to Public Advocacy
Across decades of clinical research and public health leadership, a recurring question emerged: Why does prevention so often struggle to gain traction, even when the evidence is strong?
Scientific insight alone does not guarantee action. Institutional incentives, political pressures, economic resistance, and human psychology shape whether early warnings are heeded.
That inquiry ultimately led to The Preventioneers: Diseases, Disasters, and the Discoveries That Changed Our World (Johns Hopkins University Press, 2026), a narrative history exploring how individuals across disciplines recognized danger early and what allowed some to succeed where others stalled.
Today, Dr. Davis writes and speaks about prevention, leadership, and the persistent gap between knowledge and action, offering perspective on how societies can respond more effectively to emerging risks before harm becomes widespread.
Connect with him on LinkedIn for ongoing commentary on prevention and public health.
Continue the Conversation
Follow Barry Davis on LinkedIn for ongoing commentary on prevention, public health, and the ideas behind The Preventioneers.
Subscribe to An Ounce of Prevention, Barry Davis’ free Substack newsletter on the history and science of prevention.
About Barry R. Davis, MD, PhD
Barry R. Davis is a physician, biostatistician, and clinical trialist whose career has centered on prevention — not only as a medical strategy, but as a societal responsibility.
He is Professor Emeritus of Biostatistics and Data Science at UTHealth Houston School of Public Health, where he previously served as Chair of the Department and Director of the Coordinating Center for Clinical Trials. He also held the Guy S. Parcel Chair in Public Health. Based in Houston and the Texas Medical Center, his work has shaped national and international approaches to cardiovascular prevention.
Dr. Davis served as Principal Investigator of ALLHAT, one of the largest hypertension trials ever conducted, and led SHEP, a landmark study demonstrating the benefits of treating systolic hypertension in older adults. He also held leadership roles in the Hypertension Detection and Follow-up Program (HDFP). He contributed to the early development of the SPRINT trial and later served on its Data and Safety Monitoring Committee.
In addition to directing large-scale trials, he has served on more than 150 Data and Safety Monitoring Committees and held leadership roles in national and international professional societies.
Honors and Recognition
Delta Omega National Honorary Membership (2026)
On November 2, 2026, Barry R. Davis, MD, PhD, was formally inducted as a National Honorary Member of Delta Omega, the national honorary society for public health, at its annual ceremony during the American Public Health Association meeting in San Antonio.
Delta Omega periodically confers honorary membership upon persons possessing exceptional qualifications, who have attained meritorious national or international distinction in the field of public health. Dr. Davis was recognized for his leadership in landmark cardiovascular clinical trials, his expertise in biostatistics, and his dedication to the science of preventive medicine as well as his contribution to public advocacy with his book, The Preventioneers: Diseases, Disasters, and the Discoveries That Changed Our World.
Previous National Honorary Members include Anthony Fauci, Vivek Murthy, Mandy Cohen, and Richard Besser. The honor carries a special historical connection. Sara Josephine Baker, one of the pioneering public health figures featured in The Preventioneers, received the same distinction in 1924, more than a century earlier.

From Research to Public Advocacy
Across decades of clinical research and public health leadership, a recurring question emerged: Why does prevention so often struggle to gain traction, even when the evidence is strong?
Scientific insight alone does not guarantee action. Institutional incentives, political pressures, economic resistance, and human psychology shape whether early warnings are heeded.
That inquiry ultimately led to The Preventioneers: Diseases, Disasters, and the Discoveries That Changed Our World (Johns Hopkins University Press, 2026), a narrative history exploring how individuals across disciplines recognized danger early and what allowed some to succeed where others stalled.
Today, Dr. Davis writes and speaks about prevention, leadership, and the persistent gap between knowledge and action, offering perspective on how societies can respond more effectively to emerging risks before harm becomes widespread.
Continue the Conversation
Follow Barry Davis on LinkedIn for ongoing commentary on prevention, public health, and the ideas behind The Preventioneers.
Subscribe to An Ounce of Prevention, Barry Davis’ free Substack newsletter on the history and science of prevention.